These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 9869177

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Meizothrombin, an intermediate of prothrombin activation, stimulates human glioblastoma cells by interaction with PAR-1-type thrombin receptors.
    Kaufmann R, Zieger M, Tausch S, Henklein P, Nowak G.
    J Neurosci Res; 2000 Mar 01; 59(5):643-8. PubMed ID: 10686592
    [Abstract] [Full Text] [Related]

  • 3. Meizothrombin, an intermediate of prothrombin cleavage potently activates renal carcinoma cells by interaction with PAR-type thrombin receptors.
    Kaufmann R, Junker U, Schilli-Westermann M, Klötzer C, Scheele J, Junker K.
    Oncol Rep; 2003 Mar 01; 10(2):493-6. PubMed ID: 12579295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of meizothrombin and meizothrombin-(des F1) in the conversion of prothrombin to thrombin by the Echis carinatus venom coagulant.
    Rhee MJ, Morris S, Kosow DP.
    Biochemistry; 1982 Jul 06; 21(14):3437-43. PubMed ID: 7052123
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.
    Antonaccio MJ, Normandin D, Serafino R, Moreland S.
    J Pharmacol Exp Ther; 1993 Jul 06; 266(1):125-32. PubMed ID: 8331553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autocatalytic peptide bond cleavages in prothrombin and meizothrombin.
    Petrovan RJ, Govers-Riemslag JW, Nowak G, Hemker HC, Tans G, Rosing J.
    Biochemistry; 1998 Feb 03; 37(5):1185-91. PubMed ID: 9477942
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells.
    Bretschneider E, Spanbroek R, Lötzer K, Habenicht AJ, Schrör K.
    Thromb Haemost; 2003 Oct 03; 90(4):704-9. PubMed ID: 14515192
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.